Volume 99, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Vietnam has a high burden of tuberculosis (TB) and multidrug-resistant (MDR) TB, but drug resistance patterns and TB transmission dynamics among TB/human immunodeficiency virus (HIV) coinfected patients are not well described. We characterized 200 isolates from TB/HIV coinfected patients diagnosed at the main TB referral hospital in Ho Chi Minh City, Vietnam. Phenotypic drug susceptibility testing (DST) for first-line drugs, spoligotyping, and 24-locus mycobacterial interspersed repetitive unit (MIRU-24) analysis was performed on all isolates. The 24-locus mycobacterial interspersed repetitive unit clusters and MDR isolates were subjected to whole genome sequencing (WGS). Most of the TB/HIV coinfected patients were young (162/174; 93.1% aged < 45 years) males (173; 86.5% male). Beijing (98; 49.0%) and Indo-Oceanic (70; 35.0%) lineage strains were most common. Phenotypic drug resistance was detected in 84 (42.0%) isolates, of which 17 (8.5%) were MDR; three additional MDR strains were identified on WGS. Strain clustering was reduced from 84.0% with spoligotyping to 20.0% with MIRU-24 typing and to 13.5% with WGS. Whole genome sequencing identified five additional clusters, or members of clusters, not recognized by MIRU-24. In total, 13 small (two to three member) WGS clusters were identified, with less clustering among drug susceptible (2/27; 7.4%) than among drug-resistant strains (25/27; 92.6%). On phylogenetic analysis, strains from TB/HIV coinfected patients were interspersed among strains from the general community; no major clusters indicating transmission among people living with HIV were detected. Tuberculosis/HIV coinfection in Vietnam was associated with high rates of drug resistance and limited genomic evidence of ongoing transmission among HIV-infected patients.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, 2017. Global Tuberculosis Report, 2017. Geneva, Switzerland: WHO.
  2. Abubakar I, 2013. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 13: 529539. [Google Scholar]
  3. McBryde ES, Meehan MT, Doan TN, Ragonnet R, Marais BJ, Guernier V, Trauer JM, , 2017. The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains. Int J Infect Dis 56: 1420. [Google Scholar]
  4. Zhang Y, Yew W, , 2009. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13: 13201330. [Google Scholar]
  5. Zhao Y, 2012. National survey of drug-resistant tuberculosis in China. N Engl J Med 366: 21612170. [Google Scholar]
  6. Ragonnet R, Trauer JM, Denholm JT, Marais BJ, McBryde ES, , 2017. High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from? BMC Infect Dis 17: 36. [Google Scholar]
  7. Marais BJ, Mlambo CK, Rastogi N, Zozio T, Duse AG, Victor TC, Marais E, Warren RM, , 2013. Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa. J Clin Microbiol 51: 18181825. [Google Scholar]
  8. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G, , 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368: 15751580. [Google Scholar]
  9. Raviglione M, 2012. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 379: 19021913. [Google Scholar]
  10. Vietnam National Tuberculosis Control Program, Ministry of Health, 2015. Report of The National Tuberculosis Control Program in 2014. Hanoi, Vietnam: Vietnam National Tuberculosis Control Program, Ministry of Health.
  11. Isaakidis P, Casas EC, Das M, Tseretopoulou X, Ntzani EE, Ford N, , 2015. Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis. Int J Tuberc Lung Dis 19: 969978. [Google Scholar]
  12. Basu S, Andrews JR, Poolman EM, Gandhi NR, Shah NS, Moll A, Moodley P, Galvani AP, Friedland GH, , 2007. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet 370: 15001507. [Google Scholar]
  13. Mai TQ, Van Anh NT, Hien NT, Lan NH, Giang DC, Hang PTT, Lan NTN, Marais BJ, Sintchenko V, , 2017. Drug resistance and Mycobacterium tuberculosis strain diversity in TB/HIV co-infected patients in Ho Chi Minh city, Vietnam. J Glob Antimicrob Resist 10: 154160. [Google Scholar]
  14. Gurjav U, Jelfs P, McCallum N, Marais BJ, Sintchenko V, , 2014. Temporal dynamics of Mycobacterium tuberculosis genotypes in New South Wales, Australia. BMC Infect Dis 14: 455. [Google Scholar]
  15. Gurjav U, Outhred AC, Jelfs P, McCallum N, Wang Q, Hill-Cawthorne GA, Marais BJ, Sintchenko V, , 2016. Whole genome sequencing demonstrates limited transmission within identified Mycobacterium tuberculosis clusters in New South Wales, Australia. PLoS One 11: e0163612. [Google Scholar]
  16. Gagneux S, Small PM, , 2007. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis. 7: 328337. [Google Scholar]
  17. Holt KE, 2018. Frequent transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection for the EsxW Beijing variant in Vietnam. Nat Genet 50: 849856. [Google Scholar]
  18. Pham Ngoc Thach TB and Lung Disease Hospital, 2016. Annual Report 2016—Pham Ngoc Thach TB and Lung Disease Hospital.
  19. Caws M, Duy PM, Tho DQ, Lan NTN, Hoa DV, Farrar J, , 2006. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J Clin Microbiol 44: 23332337. [Google Scholar]
  20. Abdel Aziz M, Laszlo A, Raviglione MC, Rieder HL, Espinal MA, Wright A, , 2003. Guidelines for Surveillance of Drug Resistance in Tuberculosis. Geneva, Switzerland: World Health Organization. WHO/CDS/TB/2003.320.
  21. Kamerbeek J, 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35: 907914. [Google Scholar]
  22. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, , 2006. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 44: 44984510. [Google Scholar]
  23. Pankhurst LJ, COMPASS-TB Study Group , 2016. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study. Lancet Respir Med 4: 4958. [Google Scholar]
  24. Price MN, Dehal PS, Arkin AP, , 2010. FastTree 2—approximately maximum-likelihood trees for large alignments. PLoS One 5: e9490. [Google Scholar]
  25. Wickham H, , 2009. ggplot2: Elegant Graphics for Data Analysis. New York, NY: Springer-Verlag New York.
  26. Bantubani N, Kabera G, Connolly C, Rustomjee R, Reddy T, Cohen T, Pym AS, , 2014. High rates of potentially infectious tuberculosis and multidrug-resistant tuberculosis (MDR-TB) among hospital inpatients in KwaZulu Natal, South Africa indicate risk of nosocomial transmission. PLoS One 9: e90868. [Google Scholar]
  27. Jamieson FB, Teatero S, Guthrie JL, Neemuchwala A, Fittipaldi N, Mehaffy C, , 2014. Whole-genome sequencing of the Mycobacterium tuberculosis Manila sublineage results in less clustering and better resolution than mycobacterial interspersed repetitive-unit-variable-number tandem-repeat (MIRU-VNTR) typing and spoligotyping. J Clin Microbiol 52: 37953798. [Google Scholar]
  28. Romero-Severson E, Skar H, Bulla I, Albert J, Leitner T, , 2014. Timing and order of transmission events is not directly reflected in a pathogen phylogeny. Mol Biol Evol 31: 24722482. [Google Scholar]
  29. Nhung NV, Hoa NB, Khanh PH, Hennig C, , 2015. Tuberculosis case notification data in Viet Nam, 2007 to 2012. Western Pac Surveill Response J 6: 714. [Google Scholar]
  30. Aia P, 2016. The burden of drug-resistant tuberculosis in Papua New Guinea: results of a large population-based survey. PLoS One 11: e0149806. [Google Scholar]
  31. Fox GJ, Anh NT, Nhung NV, Loi NT, Hoa NB, Ngoc Anh LT, Cuong NK, Buu TN, Marks GB, Menzies D, , 2017. Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis. Int J Tuberc Lung Dis 21: 297302. [Google Scholar]
  32. Nhu NT, Lan NT, Phuong NT, Chau Nv, Farrar J, Caws M, , 2012. Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes. Int J Tuberc Lung Dis 16: 527531. [Google Scholar]
  33. Quy HT, Buu TN, Cobelens FGJ, Lan NTN, Lambregts CSB, Borgdorff MW, , 2006. Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 10: 160166. [Google Scholar]
  34. Gurjav U, Erkhembayar B, Burneebaatar B, Narmandakh E, Tumenbayar O, Hill-Cawthorne GA, Marais BJ, Sintchenko V, , 2016. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs. Tuberculosis (Edinb) 101: 4953. [Google Scholar]
  35. Hang NTL, 2013. Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors. PLoS One 8: e71867. [Google Scholar]
  36. Tudo G, 2010. Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona. J Antimicrob Chemother 65: 23412346. [Google Scholar]
  37. Smittipat N, 2016. Mutations in rrs, rpsL and gidB in streptomycin-resistant Mycobacterium tuberculosis isolates from Thailand. J Glob Antimicrob Resist 4: 510. [Google Scholar]
  38. Coll F, 2018. Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis. Nat Genet 50: 307316. [Google Scholar]
  39. Ahmad S, Mokaddas E, Al-Mutairi N, Eldeen HS, Mohammadi S, , 2016. Discordance across phenotypic and molecular methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a low TB incidence country. PLoS One 11: e0153563. [Google Scholar]
  40. Piersimoni C, Olivieri A, Benacchio L, Scarparo C, , 2006. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol 44: 2028. [Google Scholar]
  41. Shea J, Halse TA, Lapierre P, Shudt M, Kohlerschmidt D, Van Roey P, Limberger R, Taylor J, Escuyer V, Musser KA, , 2017. Comprehensive whole-genome sequencing and reporting of drug resistance profiles on clinical cases of Mycobacterium tuberculosis in New York state. J Clin Microbiol 55: 18711882. [Google Scholar]
  42. Van Deun A, Aung KJM, Bola V, Lebeke R, Hossain MA, de Rijk WB, Rigouts L, Gumusboga A, Torrea G, de Jong BC, , 2013. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol 51: 26332640. [Google Scholar]
  43. Schleusener V, Köser CU, Beckert P, Niemann S, Feuerriegel S, , 2017. Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools. Sci Rep 7: 46327. [Google Scholar]
  44. Zhang Y, Yew WW, , 2015. Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015. Int J Tuberc Lung Dis 19: 12761289. [Google Scholar]
  45. Chakravorty S, 2017. The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. MBio 8: e00812e00817. [Google Scholar]
  46. Walker TM, Modernizing Medical Microbiology (MMM) Informatics Group , 2015. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15: 11931202. [Google Scholar]
  47. Sanchez-Padilla E, Merker M, Beckert P, Jochims F, Dlamini T, Kahn P, Bonnet M, Niemann S, , 2015. Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med 372: 11811182. [Google Scholar]
  48. Van Deun A, Wright A, Zignol M, Weyer K, Rieder HL, , 2011. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories. Int J Tuberc Lung Dis 15: 116124. [Google Scholar]
  49. Kim SJ, , 2005. Drug-susceptibility testing in tuberculosis: methods and reliability of results. Eur Respir J 25: 564569. [Google Scholar]
  50. Jou R, Chiang CY, Yu CY, Wu MH, , 2009. Proficiency of drug susceptibility testing for Mycobacterium tuberculosis in Taiwan. Int J Tuberc Lung Dis 13: 11421147. [Google Scholar]
  51. Shi R, Zhang J, Otomo K, Zhang G, Sugawara I, , 2007. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China. Antimicrob Agents Chemother 51: 45154517. [Google Scholar]
  52. Von Groll A, Martin A, Jureen P, Hoffner S, Vandamme P, Portaels F, Palomino JC, da Silva PA, , 2009. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. Antimicrob Agents Chemother 53: 44984500. [Google Scholar]
  53. Li J, Gao X, Luo T, Wu J, Sun G, Liu Q, Jiang Y, Zhang Y, Mei J, Gao Q, , 2014. Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis. Emerg Microbes Infect 3: e19. [Google Scholar]
  54. Grossman RF, Hsueh P-R, Gillespie SH, Blasi F, , 2014. Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones. Int J Infect Dis 18: 1421. [Google Scholar]
  55. Jeon CY, Calver AD, Victor TC, Warren RM, Shin SS, Murray MB, , 2011. Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community. Int J Tuberc Lung Dis 15: 7783. [Google Scholar]
  56. Trinh QM, Nguyen HL, Do TN, Nguyen VN, Nguyen BH, Nguyen TVA, Sintchenko V, Marais BJ, , 2016. Tuberculosis and HIV co-infection in Vietnam. Int J Infect Dis 46: 5660. [Google Scholar]
  57. Dellar RC, Dlamini S, Karim QA, , 2015. Adolescent girls and young women: key populations for HIV epidemic control. J Int AIDS Soc 18 (Suppl 1): 19408. [Google Scholar]

Data & Media loading...

Supplemental figure and tables

  • Received : 04 Mar 2018
  • Accepted : 20 Jun 2018
  • Published online : 29 Oct 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error